BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 18060034)

  • 1. In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation.
    Seshasayee D; Lee WP; Zhou M; Shu J; Suto E; Zhang J; Diehl L; Austin CD; Meng YG; Tan M; Bullens SL; Seeber S; Fuentes ME; Labrijn AF; Graus YM; Miller LA; Schelegle ES; Hyde DM; Wu LC; Hymowitz SG; Martin F
    J Clin Invest; 2007 Dec; 117(12):3868-78. PubMed ID: 18060034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OX40-OX40L interactions: a promising therapeutic target for allergic diseases?
    Wang YH; Liu YJ
    J Clin Invest; 2007 Dec; 117(12):3655-7. PubMed ID: 18074001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short ragweed pollen triggers allergic inflammation through Toll-like receptor 4-dependent thymic stromal lymphopoietin/OX40 ligand/OX40 signaling pathways.
    Li DQ; Zhang L; Pflugfelder SC; De Paiva CS; Zhang X; Zhao G; Zheng X; Su Z; Qu Y
    J Allergy Clin Immunol; 2011 Dec; 128(6):1318-1325.e2. PubMed ID: 21820713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine H4 receptor regulates Th2-cytokine profile through thymic stromal lymphopoietin in allergic rhinitis.
    Wang WW; Pan YL; Yu HW; Zhang B; Shao SW
    Eur Arch Otorhinolaryngol; 2019 Jun; 276(6):1655-1661. PubMed ID: 30848348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-33 promotes the induction and maintenance of Th2 immune responses by enhancing the function of OX40 ligand.
    Murakami-Satsutani N; Ito T; Nakanishi T; Inagaki N; Tanaka A; Vien PT; Kibata K; Inaba M; Nomura S
    Allergol Int; 2014 Sep; 63(3):443-55. PubMed ID: 24851948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymic stromal lymphopoietin: a promising therapeutic target for allergic diseases.
    Wang WL; Li HY; Zhang MS; Gao PS; He SH; Zheng T; Zhu Z; Zhou LF
    Int Arch Allergy Immunol; 2013; 160(1):18-26. PubMed ID: 22948028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CpG-ODNs and Budesonide Act Synergistically to Improve Allergic Responses in Combined Allergic Rhinitis and Asthma Syndrome Induced by Chronic Exposure to Ovalbumin by Modulating the TSLP-DC-OX40L Axis.
    Li HT; Chen ZG; Lin YS; Liu H; Ye J; Zou XL; Wang YH; Yang HL; Zhang TT
    Inflammation; 2018 Aug; 41(4):1304-1320. PubMed ID: 29654433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OX40/OX40 ligand interactions in T-cell regulation and asthma.
    Kaur D; Brightling C
    Chest; 2012 Feb; 141(2):494-499. PubMed ID: 22315115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amygdalin Improves Allergic Asthma via the Thymic Stromal Lymphopoietin-dendritic Cell-OX40 Ligand Axis in a Mouse Model.
    Cui W; Zhou H; Liu YZ; Yang Y; Hu YZ; Han ZP; Yu JE; Xue Z
    Iran J Allergy Asthma Immunol; 2023 Oct; 22(5):430-439. PubMed ID: 38085145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory syncytial virus nonstructural protein 1 breaks immune tolerance in mice by downregulating Tregs through TSLP-OX40/OX40L-mTOR axis.
    Fan P; Liu Z; Zheng M; Chen M; Xu Y; Zhao D
    Mol Immunol; 2021 Oct; 138():20-30. PubMed ID: 34332182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TSLP and downstream molecules in experimental mouse allergic conjunctivitis.
    Zheng X; Ma P; de Paiva CS; Cunningham MA; Hwang CS; Pflugfelder SC; Li DQ
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3076-82. PubMed ID: 20107175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins can suppress DC-mediated Th2 responses through the repression of OX40-ligand and CCL17 expression.
    Inagaki-Katashiba N; Ito T; Inaba M; Azuma Y; Tanaka A; Phan V; Kibata K; Satake A; Nomura S
    Eur J Immunol; 2019 Nov; 49(11):2051-2062. PubMed ID: 31269241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymic stromal lymphopoietin receptor blockade reduces allergic inflammation in a cynomolgus monkey model of asthma.
    Cheng DT; Ma C; Niewoehner J; Dahl M; Tsai A; Zhang J; Gonsiorek W; Apparsundaram S; Pashine A; Ravindran P; Jung J; Hang J; Allard J; Bitter H; Tribouley C; Narula S; Wilson S; Fuentes ME
    J Allergy Clin Immunol; 2013 Aug; 132(2):455-62. PubMed ID: 23810153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes from Thymic Stromal Lymphopoietin-Activated Dendritic Cells Promote Th2 Differentiation through the OX40 Ligand.
    Huang L; Zhang X; Wang M; Chen Z; Yan Y; Gu W; Tan J; Jiang W; Ji W
    Pathobiology; 2019; 86(2-3):111-117. PubMed ID: 30408778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basophil-associated OX40 ligand participates in the initiation of Th2 responses during airway inflammation.
    Di C; Lin X; Zhang Y; Zhong W; Yuan Y; Zhou T; Liu J; Xia Z
    J Biol Chem; 2015 May; 290(20):12523-36. PubMed ID: 25839234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymic stromal lymphopoietin, OX40-ligand, and interleukin-25 in allergic responses.
    Wang YH; Liu YJ
    Clin Exp Allergy; 2009 Jun; 39(6):798-806. PubMed ID: 19400908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imidazoquinoline acts as immune adjuvant for functional alteration of thymic stromal lymphopoietin-mediated allergic T cell response.
    Torii Y; Ito T; Amakawa R; Sugimoto H; Amuro H; Tanijiri T; Katashiba Y; Ogata M; Yokoi T; Fukuhara S
    J Immunol; 2008 Oct; 181(8):5340-9. PubMed ID: 18832690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand.
    Ito T; Wang YH; Duramad O; Hori T; Delespesse GJ; Watanabe N; Qin FX; Yao Z; Cao W; Liu YJ
    J Exp Med; 2005 Nov; 202(9):1213-23. PubMed ID: 16275760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell-mediated allergic inflammation.
    Liu YJ
    J Allergy Clin Immunol; 2007 Aug; 120(2):238-44; quiz 245-6. PubMed ID: 17666213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhinovirus infection interferes with induction of tolerance to aeroantigens through OX40 ligand, thymic stromal lymphopoietin, and IL-33.
    Mehta AK; Duan W; Doerner AM; Traves SL; Broide DH; Proud D; Zuraw BL; Croft M
    J Allergy Clin Immunol; 2016 Jan; 137(1):278-288.e6. PubMed ID: 26100084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.